Cargando...
Development of selective, fluorescent cannabinoid type 2 receptor ligands based on a 1,8-naphthyridin-2-(1H)-one-3-carboxamide scaffold
Cannabinoid type 2 (CB(2)) receptor has been implicated in several diseases and conditions, however no CB(2) receptor selective drugs have made it to market. The aim of this study was to develop fluorescent ligands as CB(2) receptor tools, to enable an increased understanding of CB(2) receptor expre...
Gardado en:
| Publicado en: | Medchemcomm |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Royal Society of Chemistry
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6301273/ https://ncbi.nlm.nih.gov/pubmed/30647881 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/c8md00448j |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|